CYTK FY 2011 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$8B

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+55.2% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$48M-1199.1% margin

Net Income

-$48M-1196.5% margin

EPS (Diluted)

$-4.06

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$46M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$53M

Total Liabilities

$5M

Stockholders' Equity

$48M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$3M	+55.2%
Gross Profit	$4M	$3M	+55.2%
Operating Income	-$48M	-$50M	+3.4%
Net Income	-$48M	-$49M	+2.9%